Treatment guidelines difer signifcantly, not only between Europe and North America but also among European coun tries [1–4]. Reasons for these diferences include antimi crobial resistance patterns, accessibility to and reimburse ment policies for medicines, and culturally and historically determined …

Bridging the gap between hospital and primary care is important as transition from one healthcare setting to another increases the risk on drug-related problems and consequent readmissions. To reduce those risks, pharmacist interventions during and after hospitalization have been frequently studied, …